RhumbLine Advisers’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
RhumbLine Advisers's BVS Position: Q2 2026 in Review
RhumbLine Advisers increased its Bioventus (BVS) stake by 5.3% in Q2 2026, buying an estimated $27.8K and bringing the position to 58,188 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #2700.
RhumbLine Advisers first reported a position in BVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $652K in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.
- RhumbLine Advisers held 58,188 shares of Bioventus worth $549K as of Q2 2026.
- RhumbLine Advisers bought 2,910 Bioventus shares in Q2 2026, an estimated $27.8K.
- Bioventus made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2700 holding.
- RhumbLine Advisers first reported a position in Bioventus in Q4 2021 and has held it in 19 quarters since.
- RhumbLine Advisers's Bioventus position peaked at $652K in Q3 2024.
- 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.